These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 27040705

  • 1. Cyclin-dependent kinase inhibitors for the treatment of chronic lymphocytic leukemia.
    Blachly JS, Byrd JC, Grever M.
    Semin Oncol; 2016 Apr; 43(2):265-73. PubMed ID: 27040705
    [Abstract] [Full Text] [Related]

  • 2. Emerging drug profile: cyclin-dependent kinase inhibitors.
    Blachly JS, Byrd JC.
    Leuk Lymphoma; 2013 Oct; 54(10):2133-43. PubMed ID: 23488658
    [Abstract] [Full Text] [Related]

  • 3. Pro-survival signal inhibition by CDK inhibitor dinaciclib in Chronic Lymphocytic Leukaemia.
    Chen Y, Germano S, Clements C, Samuel J, Shelmani G, Jayne S, Dyer MJ, Macip S.
    Br J Haematol; 2016 Nov; 175(4):641-651. PubMed ID: 27469405
    [Abstract] [Full Text] [Related]

  • 4. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
    Roskoski R.
    Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
    [Abstract] [Full Text] [Related]

  • 5. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms.
    Senderowicz AM.
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S61-73. PubMed ID: 12819936
    [Abstract] [Full Text] [Related]

  • 6. The impact of CDK inhibition in human malignancies associated with pronounced defects in apoptosis: advantages of multi-targeting small molecules.
    Węsierska-Gądek J, Kramer MP.
    Future Med Chem; 2012 Mar; 4(4):395-424. PubMed ID: 22416772
    [Abstract] [Full Text] [Related]

  • 7. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
    Roskoski R.
    Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
    [Abstract] [Full Text] [Related]

  • 8. Alvocidib (flavopiridol) for the treatment of chronic lymphocytic leukemia.
    Wiernik PH.
    Expert Opin Investig Drugs; 2016 Jun; 25(6):729-34. PubMed ID: 26998706
    [Abstract] [Full Text] [Related]

  • 9. Signal transduction inhibitors in chronic lymphocytic leukemia.
    Ma S, Rosen ST.
    Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K, Jones JA.
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [Abstract] [Full Text] [Related]

  • 13. Clinical activity of alvocidib (flavopiridol) in acute myeloid leukemia.
    Zeidner JF, Karp JE.
    Leuk Res; 2015 Dec; 39(12):1312-8. PubMed ID: 26521988
    [Abstract] [Full Text] [Related]

  • 14. Cyclin-dependent kinase modulators and cancer therapy.
    Gallorini M, Cataldi A, di Giacomo V.
    BioDrugs; 2012 Dec 01; 26(6):377-91. PubMed ID: 22928661
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27.
    Decker T, Schneller F, Hipp S, Miething C, Jahn T, Duyster J, Peschel C.
    Leukemia; 2002 Mar 01; 16(3):327-34. PubMed ID: 11896535
    [Abstract] [Full Text] [Related]

  • 16. Novel potent pharmacological cyclin-dependent kinase inhibitors.
    Węsierska-Gądek J, Chamrád I, Kryštof V.
    Future Med Chem; 2009 Dec 01; 1(9):1561-81. PubMed ID: 21425979
    [Abstract] [Full Text] [Related]

  • 17. A targeted therapy for protein and lipid kinases in chronic lymphocytic leukemia.
    Robak P, Robak T.
    Curr Med Chem; 2012 Dec 01; 19(31):5294-318. PubMed ID: 22830347
    [Abstract] [Full Text] [Related]

  • 18. Promotion of apoptosis in cancer cells by selective purine-derived pharmacological CDK inhibitors: one outcome, many mechanisms.
    Węsierska-Gądek J, Maurer M.
    Curr Pharm Des; 2011 Dec 01; 17(3):256-71. PubMed ID: 21348827
    [Abstract] [Full Text] [Related]

  • 19. Fludarabine-induced apoptosis of B chronic lymphocytic leukemia cells includes early cleavage of p27kip1 by caspases.
    Sanhes L, Tang R, Delmer A, DeCaprio JA, Ajchenbaum-Cymbalista F.
    Leukemia; 2003 Jun 01; 17(6):1104-11. PubMed ID: 12764376
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.